Share
Back to top
Janssen Oncology
-
For World Health Day, learn how Johnson & Johnson’s commitment to Diversity, Equity and Inclusion is helping to deliver transformational cancer treatments and solutions that reach the patients who need them most.
-
A commitment to social responsibility and innovation are just two of the attributes that helped the company land a spot on the prestigious list once again.
-
Rates of this blood cancer have jumped more than 125% worldwide since the 1990s. But there's reason to have hope: Today, life expectancy has at least doubled in some cases. That's thanks to increased research, new learnings and innovative advances—and Johnson & Johnson is at the forefront of this crucial work.
-
For National Cancer Prevention Month, we’re spotlighting three leading Johnson & Johnson female hematologists—innovators who are not only saving lives and advancing new treatments but also paving the way for the next generation of women in their field.
-
A life-threatening condition that afflicts young cancer patients. A rare and painful form of pediatric arthritis. Learn about how Johnson & Johnson is innovating to use existing medications to help kids with these illnesses—and meet two women on the forefront of this game-changing work.
-
Algorithms, artificial intelligence, machine learning and other technologies are transforming the way physicians identify, treat and manage diseases. Here’s how Johnson & Johnson is putting the latest tools to work.
-
That's exactly what researchers at Johnson & Johnson are trying to find out. By partnering on a new study that's looking at the role gut microbes may play in the disease—and focusing on the underrepresented groups most affected—they hope to advance early-detection strategies and potential treatments.
-
Learn how J&J landed on the global corporate reputation list for the 20th year in a row and ranked #1 on the Pharmaceutical Industry list for the ninth consecutive year.
-
Artificial intelligence-enabled mobile screening units. Nasal swab genomic tests. Diagnostics that pair the right treatment with the right patient. For National Cancer Prevention Month, Johnson & Johnson researchers share the progress that's being made to thwart the #1 cancer killer.
-
Certain gene mutations can dramatically increase the risk of developing aggressive prostate cancer. That's why Johnson & Johnson is researching a new way to fight the disease—one that involves blocking cancer cells from repairing their own damaged DNA.
-
Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.
-
Despite obstacles and setbacks, these researchers vowed to never give up working to develop a new treatment for non-small cell lung cancer. For Lung Cancer Awareness Month, they share their journey.
-
Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.
-
Surprising new research suggests that people younger than 50 are getting diagnosed with the disease at record rates. For National Cancer Research Month, find out how to protect yourself—no matter your age.
-
For National Cancer Prevention Month, we retrace the 22-year journey it took to bring a potentially life-changing treatment for an aggressive form of bladder cancer to patients who may benefit most.
